Cartesian Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Cartesian Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cartesian Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cartesian Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $182k | 18k | 10.22 |
| 2025-06-30 | $317k | 31k | 10.35 |
| 2025-03-31 | $190k | 14k | 13.22 |
| 2024-12-31 | $342k | 19k | 17.91 |
| 2024-09-30 | $188k | 12k | 16.19 |
| 2024-06-30 | $102k | 3.8k | 27.11 |